|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||2.47 / 6.19|
Investigating New Patient Cohort with Cervical Injury
TheStreet's biotech columnist offers his own report card on biotech stocks.
NSI-189 Shows Reversal of Radiation-induced Cognitive Deficits
NSI-189 Shows Prevention and Reversal of Diabetic Neuropathies in Mice
Dr. Karl Johe Resigns from Board of Directors; Company Announces Creation of Scientific Policy Committee with Dr. Johe as Chairman
Data Contribute to Understanding NSI-189 Mechanism of Action
These under-$10 stocks are ready to move higher from current levels. Here's how to trade them from here.
Trial Efficacy Endpoints Include Reduction in Depression and Cognition Improvement